Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Deutsches Arzteblatt International|February 10, 2022
The Prevention and Treatment of Nausea and Vomiting During Tumor TherapyFranziska Jahn, Bernhard Wörmann, Juliane Brandt, et al.
Journal of Neurology|January 27, 2016
Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imagingBerit Jordan, Juliane Kellner, Karin Jordan, et al.
Deutsches Arzteblatt International|August 3, 2017
Supportive Treatments for Patients with CancerKarin Jordan, Petra Feyer, Ulrike Höller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 26, 2018
Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based ChemotherapySnežana M Bošnjak, Ljiljana Stamatovic, Maria Elisa Borroni, et al.
Deutsches Arzteblatt International|March 27, 2014
Cardiotoxicity and oncological treatmentsAxel Schlitt, Karin Jordan, Dirk Vordermark, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2015
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysisKarin Jordan, David G Warr, Axel Hinke, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2015
Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant CisplatinFranziska Jahn, Anica Riesner, Patrick Jahn, et al.
Current Cancer Drug Targets|May 16, 2022
Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily PracticeMatti Aapro, Karin Jordan, Florian Scotté, et al.
Onkologie|July 4, 2008
Venous access ports: frequency and management of complications in oncology patientsKarin Jordan, Timo Behlendorf, Alexey Surov, et al.
Oncology Research and Treatment|January 15, 2023
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with CancerKarin Jordan, Evandro De Azambuja, Teresa Amaral, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Deutsches Arzteblatt International|February 10, 2022
The Prevention and Treatment of Nausea and Vomiting During Tumor TherapyFranziska Jahn, Bernhard Wörmann, Juliane Brandt, et al.
Journal of Neurology|January 27, 2016
Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imagingBerit Jordan, Juliane Kellner, Karin Jordan, et al.
Deutsches Arzteblatt International|August 3, 2017
Supportive Treatments for Patients with CancerKarin Jordan, Petra Feyer, Ulrike Höller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 26, 2018
Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based ChemotherapySnežana M Bošnjak, Ljiljana Stamatovic, Maria Elisa Borroni, et al.
Deutsches Arzteblatt International|March 27, 2014
Cardiotoxicity and oncological treatmentsAxel Schlitt, Karin Jordan, Dirk Vordermark, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 19, 2015
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysisKarin Jordan, David G Warr, Axel Hinke, et al.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2015
Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant CisplatinFranziska Jahn, Anica Riesner, Patrick Jahn, et al.
Current Cancer Drug Targets|May 16, 2022
Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily PracticeMatti Aapro, Karin Jordan, Florian Scotté, et al.
Onkologie|July 4, 2008
Venous access ports: frequency and management of complications in oncology patientsKarin Jordan, Timo Behlendorf, Alexey Surov, et al.
Oncology Research and Treatment|January 15, 2023
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with CancerKarin Jordan, Evandro De Azambuja, Teresa Amaral, et al.
Pageof 11